[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 21, Issue 2 (Iranian South Medical Journal 2018) ::
Iran South Med J 2018, 21(2): 116-124 Back to browse issues page
Lethal Effect of Various Derivatives of Curcumin on Trichomonas vaginalis in vitro
MoradAli Fouladvand1 , Afshin Barazesh2, Rahim Tahmasebi3, Khosro Mohammadi4, Soliman Khorami 5
1- Department of Microbiology and Parasitology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran
2- Department of Laboratory Sciences, School of Paramedicine, Bushehr University of Medical Sciences, Bushehr, Iran
3- Department of Health, Bushehr University of Medical Sciences, Bushehr, Iran
4- Department of Chemistry, College of Sciences, Persian Gulf University, Bushehr, Iran
5- Department of Microbiology and Parasitology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran , khorami_bu@yahoo.com
Abstract:   (2026 Views)

Background: Trichomoniasis is a common urogenital disease in the world. The first line of treatment for Trichomoniasis is metronidazole. Drug resistance and side effects of metronidazole urge researchers to seek new medications. Curcumin is a yellow substance derived from turmeric and has different derivatives with anticancer and antioxidant effects. We evaluated the anti-trichomonas effects of curcumin and its derivatives.

Materials and Methods: Curcumin 70%, curcumin 90%, Bisdemethoxy curcumin, Diacetyl curcumin, Vanadyl curcumin, Vanadyl diacetyl curcumin, Indium curcumin and Gallium curcumin were prepared. Different concentrations (50, 100, 200, 400, 600, 800 µg/ml) of curcumin prepared with glycerin and 106 Trichomonas vaginalis were added to each well and incubated at 37°C for 24 h. The in vitro toxicity of different extracts against Trichomonas vaginalis was evaluated through MTT assay. All tests were performed in triplicate and SPSS software was used for data analysis.

Results: The IC50 was 450, 400, 441, 453.2, 427.3, 417.6, 441 and 449.1 µg/ml, respectively for curcumin 70%, curcumin 90%, Bisdemethoxy curcumin, Diacetyl curcumin, Vanadyl curcumin, Vanadyl diacetyl curcumin, Indium curcumin and Gallium curcumin against Trichomonas vaginalis. Cytotoxic effects of these compounds against vero cells were 33.1%, 19%, 21%, 20.3%, 17%, 21%, 25.3% and 16%, respectively.
Conclusion: Curcumin 90% had the most activity against Trichomonas vaginalis and Galium curcumin had the least cytotoxic effect against vero cells. It appears curcumin lotion can be used topically to treat trichomoniasis.

Keywords: Trichomonas vaginalis, Curcumin, MTT, Vero
Full-Text [PDF 689 kb]   (570 Downloads)    
Type of Study: Original | Subject: Microbiology and Immunology
Received: 2018/06/20 | Accepted: 2018/06/20 | Published: 2018/06/20
References
1. Newman L, Rowley J, Vander Hoorn S, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting PloS one 2015;10(12): e0143304. [DOI:10.1371/journal.pone.0143304]
2. Geelen TH, Hoebe CJ, Dirks A, et al. Low positivity rate after systematic screening for Trichomonas vaginalis in three patient cohorts from general practitioners, STI clinic and a national population-based chlamydia screening study. Sex Transm Infect 2013;89(6):532-4. [DOI:10.1136/sextrans-2012-051010]
3. Shew ML, Fortenberry JD, Tu W, et al. Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women. Archives of pediatrics & adolescent medicine 2006; 160(2): 151-6. [DOI:10.1001/archpedi.160.2.151]
4. Gottlieb SL, Douglas JM, Foster M, et al. Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. Journal of Infectious Diseases 2004; 190(6): 1059-67. [DOI:10.1086/423323]
5. McClelland RS, Sangaré L, Hassan WM, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. Journal of Infectious Diseases 2007; 195(5):698-702. [DOI:10.1086/511278]
6. Van Der Pol B, Kwok C, Pierre-Louis B, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. Journal of Infectious Diseases 2008; 197(4):548-54. [DOI:10.1086/526496]
7. Kissinger P, Amedee A, Clark RA, et al. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sexually transmitted diseases 2009; 36(1):11-6. [DOI:10.1097/OLQ.0b013e318186decf]
8. Schmid G, Narcisi E, Mosure D, et al. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. The Journal of reproductive medicine 2001;46(6):545-9. [DOI:10.1097/00006254-200111000-00015]
9. Hager WD. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients. Sexually transmitted diseases 2004; 31(6):343-5. [DOI:10.1097/00007435-200406000-00004]
10. Petrin D, Delgaty K, Bhatt R, et al. Clinical and microbiological aspects ofTrichomonas vaginalis. Clinical microbiology reviews 1998; 11(2):300-17. [DOI:10.1128/CMR.11.2.300]
11. Connor TH, Stoeckel M, Evrard J, et al. The contribution of metronidazole and two metabolites to the mutagenic activity detected in urine of treated humans and mice. Cancer research 1977; 37(2):629-33.
12. Lindmark DG, Müller M. Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles. Antimicrobial agents and chemotherapy 1976;10(3):476-82. [DOI:10.1128/AAC.10.3.476]
13. Koss CA, Baras DC, Lane SD, et al. Investigation of metronidazole use during pregnancy and adverse birth outcomes. Antimicrobial agents and chemotherapy 2012; AAC-06477-11.
14. Clark AM. Natural products as a resource for new drugs. Pharmaceutical research 1996; 13(8): 1133-41. [DOI:10.1023/A:1016091631721]
15. Chattopadhyay I, Biswas K, Bandyopadhyay U, et al. Turmeric and curcumin: Biological actions and medicinal applications. CURRENT SCIENCE-BANGALORE 2004; 87(1): 44-53.
16. Perez-Arriaga L, Mendoza-Magana ML, CortesZarate R, et al. Cytotoxic effect of curcumin on Giardia lamblia trophozoites. Acta tropica 2006; 98(2): 152-61. [DOI:10.1016/j.actatropica.2006.03.005]
17. Khalafalla RE, Müller U, Shahiduzzaman MD, et al. Effects of curcumin (diferuloylmethane) on Eimeria tenella sporozoites in vitro. Parasitology research 2011; 108(4): 879-86 [DOI:10.1007/s00436-010-2129-y]
18. Mimche PN, Taramelli D, Vivas L. The plantbased immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria. Malaria journal 2011; 10(1):S10. [DOI:10.1186/1475-2875-10-S1-S10]
19. Shahiduzzaman M, Dyachenko V, Khalafalla RE, et al. Effects of curcumin on Cryptosporidium parvum in vitro. Parasitology research. 2009;105(4):1155-61. [DOI:10.1007/s00436-009-1535-5]
20. Koide T, Nose M, Ogihara Y, et al. Leishmanicidal effect of curcumin in vitro. Biological and Pharmaceutical Bulletin 2002; 25(1): 131-3. [DOI:10.1248/bpb.25.131]
21. Changtam C, de Koning HP, Ibrahim H, et al. Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species. European journal of medicinal chemistry 2010; 45(3): 941-56. [DOI:10.1016/j.ejmech.2009.11.035]
22. Allam G. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni. Immunobiology 2009; 214(8): 712-27. [DOI:10.1016/j.imbio.2008.11.017]
23. Jordan WC, Drew CR. Curcumin--a natural herb with anti-HIV activity. Journal of the National Medical Association 1996; 88(6): 333.
24. Barthelemy S, Vergnes L, Moynier M, Guyot D, Labidalle S, Bahraoui E. Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat. Research in virology 1998; 28;149(1):43-52. [DOI:10.1016/S0923-2516(97)86899-9]
25. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). The Journal of Alternative & Complementary Medicine 2044; 9(1): 161-8. [DOI:10.1089/107555303321223035]
26. Wei QY, Chen WF, Zhou B, et al. Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues. Biochimica et Biophysica Acta (BBA)-General Subjects 2006; 1760(1):70-7. [DOI:10.1016/j.bbagen.2005.09.008]
27. Devasena T, Rajasekaran KN, Gunasekaran G, et al. Anticarcinogenic effect of bis-1, 7-(2- hydroxyphenyl)-hepta-1, 6-diene-3, 5-dione a curcumin analog on DMH-induced colon cancer model. Pharmacological research 2003; 47(2):133-40. [DOI:10.1016/S1043-6618(02)00283-9]
28. Mohammadi K, Thompson KH, Patrick BO, et al. Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications. Journal of inorganic biochemistry 2005; 99(11): 2217-25. [DOI:10.1016/j.jinorgbio.2005.08.001]
29. Liang G, Yang S, Jiang L, et al. Synthesis and anti-bacterial properties of mono-carbonyl analogues of curcumin. Chemical and Pharmaceutical Bulletin 2008; 56(2): 162-7. [DOI:10.1248/cpb.56.162]
30. Dubey SK, Sharma AK, Narain U, et al. synthesis and characterization of some bioactive conjugates of curcumin with glycine, glutamic acid, valine and demethylenated piperic acid and study of their antimicrobial and antiproliferative properties. European journal of medicinal chemistry 2008; 43(9):1837-46. [DOI:10.1016/j.ejmech.2007.11.027]
31. Khan IA, Abourashed EA. Leung's encyclopedia of common natural ingredients: used in food, drugs and cosmetics. John Wiley & Sons 2011; 50.
32. Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta medica 1991; 57(1): 1-7. [DOI:10.1055/s-2006-960004]
33. Hamidi A, Hassani L, Mohammadi F, et al. The biological effects of vanadyl curcumin and vanadyl diacetylcurcumin complexes: the effect on structure, function and oxidative stability of the peroxidase enzyme, antibacterial activity and cytotoxic effect. Journal of enzyme inhibition and medicinal chemistry 2016; 31(6): 1124-31. [DOI:10.3109/14756366.2015.1101091]
34. Jahangoshaei P, Hassani L, Mohammadi F, et al. Investigating the effect of gallium curcumin and gallium diacetylcurcumin complexes on the structure, function and oxidative stability of the peroxidase enzyme and their anticancer and antibacterial activities. JBIC Journal of Biological Inorganic Chemistry. 2015;20(7):1135-46. [DOI:10.1007/s00775-015-1295-x]
35. Zandi K, Ahmadzadeh S, Tajbakhsh S, et al. Anticancer activity of Sargassum oligocystum water extract against human cancer cell lines. European review for medical and pharmacological sciences 2010; 14(8):669-73. (Persian)
36. Mwololo SW, Mutiso JM, Macharia JC, et al. In vitro activity and in vivo efficacy of a combination therapy of diminazene and chloroquine against murine visceral leishmaniasis. Journal of biomedical research 2015; 29(3): 214-23.
37. Mahmoudvand H, Sepahvand P, Jahanbakhsh S, et al Evaluation of the antileishmanial and cytotoxic effects of various extracts of garlic (Allium sativum) on Leishmania tropica. Journal of Parasitic Diseases 2016; 40(2):423-6. [DOI:10.1007/s12639-014-0520-9]
38. Arabsalmany M, Behzadifar M, Olyaeemanesh A, et al The prevalence of herpes simplex virus of pregnancy in Iran: A systematic review and meta-analysis. Iranian Journal of Child Neurology 2016; 11(2):11309. (Persian)
39. Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clinical Infectious Diseases 2001; 15; 33(8): 1341-6. [DOI:10.1086/323034]
40. Khalafalla RE, Müller U, Shahiduzzaman MD, et al. Effects of curcumin (diferuloylmethane) on Eimeria tenella sporozoites in vitro. Parasitology research 2011; 108(4): 879-86. [DOI:10.1007/s00436-010-2129-y]
41. Fang HY, Chen SB, Guo DJ, et al. Proteomic identification of differentially expressed proteins in curcumin-treated MCF-7 cells. Phytomedicine 2011; 18(8-9): 697-703. [DOI:10.1016/j.phymed.2010.11.012]
42. Wang L, Wang L, Song R, et al. Targeting sarcoplasmic/endoplasmic reticulum Ca2+- ATPase 2 by curcumin induces ER stressassociated apoptosis for treating human liposarcoma. Molecular cancer therapeutics 2011; 10(3): 461-71. [DOI:10.1158/1535-7163.MCT-10-0812]
43. Wachter B, Syrowatka M, Obwaller A, et al. In vitro efficacy of curcumin on Trichomonas vaginalis. Wiener klinische Wochenschrift. 2014; 126(1):32-6. [DOI:10.1007/s00508-014-0522-8]
44. Manifar S, Obwaller A, Gharehgozloo A, et al. Curcumin gel in the treatment of minor aphthous ulcer: A randomized, placebo-controlled trial. Journal of Medicinal Plants 2012; 15;1(41):40-5. (Persian)
45. Helson L. Curcumin (diferuloylmethane) delivery methods: a review. Biofactors 2013; 39(1): 21-6. [DOI:10.1002/biof.1080]
46. Patel BM, Mandal S, Rajesh KS. Formulation and kinetic modeling of curcumin loaded intranasal mucoadhesive microemulsion. Journal of Pharmacy and Bioallied Sciences 2012; 4(5): S81-S83. [DOI:10.4103/0975-7406.94148]
47. Berginc K, Škalko-Basnet N, Basnet P, et al. Development and evaluation of an in vitro vaginal model for assessment of drug's biopharmaceutical properties: Curcumin. AAPS PharmSciTech 2012; 13(4): 1045-53. [DOI:10.1208/s12249-012-9837-9]
48. Di Pierro F, Rapacioli G, Di Maio EA, Appendino G, Franceschi F, Togni S. Comparative evaluation of the pain-relieving properties of a lecithinized formulation of curcumin (Meriva®), nimesulide, and acetaminophen. J Pain Res 2013; 6: 201-5. [DOI:10.2147/JPR.S42184]
49. Kulac M, Aktas C, Tulubas F, et al. The effects of topical treatment with curcumin on burn wound healing in rats. Journal of Molecular Histology 2013; 44(1): 83-90. [DOI:10.1007/s10735-012-9452-9]
50. Mohammaddoust S, Salehi Z, Saeidi Saedi H. Analysis of Ala234Thr Polymorphism SEPP1 gene in Women with Breast Cancer in Guilan Province. ISMJ. 2018 Jan 15;20(6):519-26.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fouladvand M, Barazesh A, Tahmasebi R, Mohammadi K, Khorami S. Lethal Effect of Various Derivatives of Curcumin on Trichomonas vaginalis in vitro. Iran South Med J. 2018; 21 (2) :116-124
URL: http://ismj.bpums.ac.ir/article-1-920-en.html


Volume 21, Issue 2 (Iranian South Medical Journal 2018) Back to browse issues page
دانشگاه علوم پزشکی بوشهر، طب جنوب ISMJ

Iranian South Medical Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License which allows users to read,
copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly

Copyright © 2017, Iranian South Medical Journal| All Rights Reserved

Persian site map - English site map - Created in 0.06 seconds with 32 queries by YEKTAWEB 4148